Industry-chain Research Brief

TCL Rechi (Huizhou) Refrigeration Equipment Ltd.: Biomedicine and medical devices Little Giant Industry Chain Brief

Guangdong · Biomedicine and medical devices · 2026-06-14

English company profile Full Chinese report All report summaries

English Summary

TCL Rechi (Huizhou) Refrigeration Equipment Ltd. is a China Little Giant company report summary for overseas readers. The company is associated with Guangdong. The report is indexed under Biomedicine and medical devices. The Chinese report was published on 2026-06-14. The summary covers company profile, product direction, industry-chain role, technology, patent/R&D signals, scale indicators and policy-material checkpoints.

Report Snapshot

CompanyTCL Rechi (Huizhou) Refrigeration Equipment Ltd.
RegionGuangdong
IndustryBiomedicine and medical devices
Published2026-06-14
Chinese reportOpen
CompanyTCL Rechi (Huizhou) Refrigeration Equipment Ltd.
Region / IndustryGuangdong · Biomedicine and medical devices
Recognition2025 7th batch
Patent signalPatent count not available

Company and Recognition Snapshot

TCL Rechi (Huizhou) Refrigeration Equipment Ltd. is indexed as a national-level Little Giant enterprise in Guangdong. The English profile places the company under Biomedicine and medical devices and records 2025 7th batch as the available recognition context.

Recognition batch2025 7th batch
RegionGuangdong
IndustryBiomedicine and medical devices
Registered capitalRMB 71.74 million
Employee signal730 employees
Listed statusNot listed
Patent signalPatent count not available
R&D signalR&D investment detail not published in the English dataset

Business and Industry-chain Position

Business scope detail is available in the Chinese source profile The recorded industry-chain position is High-end equipment and industrial automation / Recorded position. This places the company in a policy-relevant segment for peer comparison by region, industry and batch.

Technology, Patent and R&D Signals

The public profile records Patent count not available. The R&D signal is: R&D investment detail not published in the English dataset. Patent and R&D information should be read with product direction, customer evidence and chain position rather than as isolated threshold items.

Policy-material Review Points

  • Verify whether the company's main business, niche market and product evidence all point to Biomedicine and medical devices.
  • Check that patent, R&D, employee and financial fields support the same core product direction.
  • Compare the company with peers in the same province, industry and recognition batch before using the profile for supplier screening or policy research.
  • Use the linked Chinese source report for original-language evidence and source links.

Original Report and Profile

For the underlying database record, open the English company profile. For full-length analysis, original-language wording and public evidence links, open the Chinese source report.

Related Search Paths